Agnès Représa

770 total citations
4 papers, 95 citations indexed

About

Agnès Représa is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Agnès Représa has authored 4 papers receiving a total of 95 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Agnès Représa's work include CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immune Cell Function and Interaction (2 papers). Agnès Représa is often cited by papers focused on CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immune Cell Function and Interaction (2 papers). Agnès Représa collaborates with scholars based in France and Switzerland. Agnès Représa's co-authors include Christian Belmant, Carine Paturel, Florence Lhospice, Eliane Fischer, Patrick Dennler, Laurent Gauthier, Delphine Brégeon, Aristeidis Chiotellis, Roger Schibli and Sophie Ingoure and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Pharmaceutics.

In The Last Decade

Agnès Représa

4 papers receiving 87 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agnès Représa France	3	74	70	34	12	9	4	95
Danielle Trancucci United States	7	96 1.3×	54 0.8×	38 1.1×	20 1.7×	4 0.4×	14	135
Mona Purcell United States	6	42 0.6×	35 0.5×	32 0.9×	24 2.0×	9 1.0×	10	100
Jeffrey Wolf United States	3	76 1.0×	23 0.3×	34 1.0×	23 1.9×	4 0.4×	3	98
Marine Richard Switzerland	5	49 0.7×	40 0.6×	22 0.6×	28 2.3×	2 0.2×	8	76
Angela Frentzen United States	4	36 0.5×	31 0.4×	55 1.6×	68 5.7×	4 0.4×	4	84
Wojciech Janowski Australia	7	107 1.4×	50 0.7×	76 2.2×	14 1.2×	3 0.3×	18	150
Agathe Dubuisson France	4	22 0.3×	13 0.2×	62 1.8×	33 2.8×	4 0.4×	6	93
Anetta Marcinek Germany	4	74 1.0×	29 0.4×	28 0.8×	74 6.2×		16	122
Drew Dudgeon United States	4	41 0.6×	41 0.6×	23 0.7×	27 2.3×		6	81
Erica Hong United States	3	38 0.5×	30 0.4×	13 0.4×	7 0.6×		5	53

Countries citing papers authored by Agnès Représa

Since Specialization

Citations

This map shows the geographic impact of Agnès Représa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Représa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Représa more than expected).

Fields of papers citing papers by Agnès Représa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Représa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Représa. The network helps show where Agnès Représa may publish in the future.

Co-authorship network of co-authors of Agnès Représa

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Représa. A scholar is included among the top collaborators of Agnès Représa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Représa. Agnès Représa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Demaria, Olivier, Marie Vétizou, Romain Remark, et al.. (2024). Preclinical assessment of IPH6501, a first-in-class IL2v-armed tetraspecific NK cell engager directed against CD20 for R/R B-NHL, in comparison with a CD20-targeting T cell engager.. Journal of Clinical Oncology. 42(16_suppl). 7030–7030. 1 indexed citations

2.

Demaria, Olivier, Éric Vivier, Marie Vétizou, et al.. (2021). 851 Harnessing innate immunity in cancer therapies: the example of natural killer cell engagers. Regular and Young Investigator Award Abstracts. A892–A892. 5 indexed citations

3.

Demaria, Olivier, Julien Carvelli, Joanna Fares, et al.. (2020). 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. SHILAP Revista de lepidopterología. A299.1–A299. 11 indexed citations

4.

Lhospice, Florence, Delphine Brégeon, Christian Belmant, et al.. (2015). Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Molecular Pharmaceutics. 12(6). 1863–1871. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact